Zobrazeno 1 - 10
of 33
pro vyhledávání: '"G E Krassas"'
Autor:
K. Gkastaris, G. E. Krassas
Publikováno v:
Thyroid Diseases in Pregnancy ISBN: 9783030987763
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22328ff4c36c7e38c89b0476817165b6
https://doi.org/10.1007/978-3-030-98777-0_9
https://doi.org/10.1007/978-3-030-98777-0_9
Autor:
G. E. Krassas, George J. Kahaly, Michele Marinò, L Baldeschi, Giovanni Veronesi, Antonella Boschi, Claudio Marcocci, Petros Perros, M Stahl, Claudio Azzolini, Marco Nardi, M. R. Soeters, Nicola Currò, M. P. Mourits, Kostas G. Boboridis, Chantal Daumerie, L. Sassi, G von Arx, W. M. Wiersinga, M Bernard, Luigi Bartalena, Mario Salvi, C Bournaud
Publikováno v:
Journal of endocrinological investigation, 40(5), 547-553. Editrice Kurtis s.r.l.
Intravenous glucocorticoids (ivGCs) given as 12-weekly infusions are the first-line treatment for moderate-to-severe and active Graves’ orbitopathy (GO), but they are not always effective. In this study, we evaluated whether response at 6 weeks cor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bde5cc5c60fc36ba6a599219d4a1f90b
https://pure.amc.nl/en/publications/does-early-response-to-intravenous-glucocorticoids-predict-the-final-outcome-in-patients-with-moderatetosevere-and-active-graves-orbitopathy(03971e8f-5400-4a24-8272-ed4e0894339e).html
https://pure.amc.nl/en/publications/does-early-response-to-intravenous-glucocorticoids-predict-the-final-outcome-in-patients-with-moderatetosevere-and-active-graves-orbitopathy(03971e8f-5400-4a24-8272-ed4e0894339e).html
Publikováno v:
European journal of endocrinology / European Federation of Endocrine Societies, 153(4), 515-520. BioScientifica Ltd.
Objective: Evaluation of the frequency of Graves’ ophthalmopathy (GO) and its management in children and adolescents up to 18 years old with Graves’ hyperthyroidism.Study design: This was a questionnaire study (QS) among members of the European T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff659140d32b480b3be3a364a451ba89
https://doi.org/10.1530/eje.1.01991
https://doi.org/10.1530/eje.1.01991
Autor:
G. E. Krassas
Publikováno v:
Journal of Endocrinological Investigation. 27:281-287
Somatostatin (SM), a peptide inhibiting the release of GH, is present and plays an inhibitory role in the regulation of several organ systems in men and other species. Various SM analogs (SM-As) have been developed and used in clinical practice becau
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b374b8d3a48a0e777fdf1bca021aa4b4
https://doi.org/10.1007/bf03345278
https://doi.org/10.1007/bf03345278
Autor:
Petros Perros, G. E. Krassas
Publikováno v:
Scopus-Elsevier
Despite the high prevalence of thyroid diseases in the general population, male reproductive function in patients with thyroid disease has been the subject of only a few studies. Hyperthyroidism appears to cause sperm abnormalities (mainly reduction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6a2e26baba2c000513c5608aa5e68e4
https://doi.org/10.1007/bf03345187
https://doi.org/10.1007/bf03345187
Publikováno v:
Nutritional Neuroscience. 3:407-414
The aim of the study was to investigate the effects of treatment with 1-thyroxine on iron and ferritin concentrations, and the efficacy of continued treatment with iron substitution and 1-thyroxine in patients with subclinical hypothyroidism and mani
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b431907aa125528ebb519f7d07f06870
https://doi.org/10.1080/1028415x.2000.11747340
https://doi.org/10.1080/1028415x.2000.11747340
Autor:
Jane Paunkovic, G. E. Krassas, Ph. Papadopoulou, Th. Kaltsas, Nebojsa Paunkovic, N. Pontikides, Leonidas H. Duntas
Publikováno v:
Clinical Endocrinology. 50:655-659
OBJECTIVES Most thyroid textbooks describe hypo-thyroidism resulting in changes in the length of the menstrual cycle and in the amount of bleeding. Our experience at a busy thyroid clinic had given a picture which differs from that presented in the l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c875ea1eb9ebd017115a7760576f7f2
https://doi.org/10.1046/j.1365-2265.1999.00719.x
https://doi.org/10.1046/j.1365-2265.1999.00719.x
Autor:
G. E. Krassas, John Lazarus, Luigi Bartalena, Eugogo, George J. Kahaly, Claudio Marcocci, W. M. Wiersinga
Publikováno v:
Journal of endocrinological investigation. 33(6)
BACKGROUND: Glucocorticoid prophylaxis is required in some instances after radioiodine (RAI) treatment for Graves' hyperthyroidism to prevent progression of Graves' orbitopathy (GO). However, no randomized clinical trial has been performed to ascerta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f044b111f5b3a6b26d9413dcb277f2a
https://pubmed.ncbi.nlm.nih.gov/20101098
https://pubmed.ncbi.nlm.nih.gov/20101098
Autor:
G. E. Krassas
Publikováno v:
European Journal of Nuclear Medicine. 28:254-256
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7afe911389888e94e5cd879b4f3d3875
https://doi.org/10.1007/s002590000426
https://doi.org/10.1007/s002590000426
Publikováno v:
European journal of endocrinology. 157(2)
Patients with thyroid eye disease, Graves’ orbitopathy (GO), often appear distressed and it is likely that features of the condition such as disturbances in visual function, orbital discomfort and alterations in facial appearance can impart signifi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41f9e972f13e42f6abea7bcdbfaebad5
https://pubmed.ncbi.nlm.nih.gov/17656589
https://pubmed.ncbi.nlm.nih.gov/17656589